Praxis Precision Medicines (PRAX) Capital Expenditures (2019 - 2025)

Praxis Precision Medicines' Capital Expenditures history runs 5 years deep, the most recent figure standing at -$8000.0 for Q2 2025.

• In Q2 2025, Capital Expenditures changed N/A year-over-year to -$8000.0; the TTM figure through Mar 2026 stood at -$8000.0 (down 112.5% YoY), while the FY2025 annual figure was $56000.0, changed N/A from the prior year.
• Capital Expenditures was -$8000.0 for Q2 2025 at Praxis Precision Medicines, down from $64000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $531000.0 in Q4 2021 to a low of -$399000.0 in Q3 2022.
• Historically, Capital Expenditures has averaged $145454.5 across 4 years, with a median of $79000.0 in 2021.
• Biggest YoY gain for Capital Expenditures was 7125.0% in 2022; the steepest drop was 191.51% in 2022.
• A 4-year view of Capital Expenditures shows it stood at $531000.0 in 2021, then retreated by 16.38% to $444000.0 in 2022, then slumped by 88.74% to $50000.0 in 2023, then tumbled by 116.0% to -$8000.0 in 2025.
• The last three Capital Expenditures figures came in at -$8000.0 (Q2 2025), $64000.0 (Q1 2025), and $50000.0 (Q3 2023), per Business Quant data.